Abbott Laboratories/ US0028241000 /
6/28/2022 9:59:54 PM | Chg. -2.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
106.98USD | -1.93% | 259,993 Turnover: 28.12 mill. |
-Bid Size: - | -Ask Size: - | 187.3 bill.USD | 1.70% | 26.94 |
GlobeNewswire
3/29
Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors
GlobeNewswire
3/24
(ABT Alert) Long Term Holders of Abbott Laboratories Contact Johnson Fistel for Information Regardin...
GlobeNewswire
3/22
Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial Results and Business Highlights
GlobeNewswire
3/2
La-Z-Boy Announces Planned Retirement of Darrell Edwards, COO; Names Mike Leggett SVP and Chief Supp...
GlobeNewswire
1/28
HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors
GlobeNewswire
1/6
Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer
Newsfile Corp
11/23/2021
A Strong Vibrant Life Sciences Sector, Pricing Regulations and Diversity, Equity and Inclusion Top P...
GlobeNewswire
11/19/2021
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
GlobeNewswire
11/15/2021
EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel
GlobeNewswire
11/15/2021
Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Dir...
GlobeNewswire
11/1/2021
Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer and Doug Barry...
GlobeNewswire
10/27/2021
HCW Biologics Announces Appointment of Two New Members to Board of Directors